Zkusit zdarma
Revance Therapeutics, Inc.

Revance Therapeutics, Inc.

RVNC
Cena:
 
 
Valuace
100
Růst
60
Zdraví
63
preloader

Finanční výsledky Revance Therapeutics, Inc. (RVNC)

Měna: USD

Ukazatel20232022202120202019
Diluted EPS-3.83-4.9-4.25-4.86-3.59
Gross Profit81.9M80.9M54.4M10.6M-102.4M
Net Income Attributable to Common Shareholders-324M-356.4M-286.8M-282.1M-156.2M
Operating Profit-316.8M-272.2M-274.7M-273.2M-164.5M
Total Revenues234M132.6M77.8M15.3M413000